Avricore Health Signs Letter of Intent to Partner with FoodRocket to Enhance the HealthTab Platform – November 27, 2018

VANCOUVER, BC, November 27, 2018 – Avricore Health Inc. (TSXV: AVCR) (“Avricore Health”) is pleased to announce that it has signed a letter of intent to review opportunities to collaborate with FoodRocket to integrate FoodRocket’s precision health offerings and genomics with the HealthTab platform across Canada. Avricore Health is actively pursuing the expansion of its […]

VANC Pharmaceuticals Inc. Provides Corporate Update – November 1, 2018

VANCOUVER, BC, November 1, 2018 – VANC Pharmaceuticals Inc. (“VANC”) is excited to announce that further to its news release announced October 25, 2018, the Company has received TSX Venture Exchange approval to change its name (the “Name Change”) to Avricore Health Inc. “We are pleased to have received TSX approval for our new name, […]